Articles

Videos

Podcasts

Clinical

There is a need to stop health disparities in our public health communities, especially in the LGBTQ+ space.

Pharmacy Focus: Public Health Matters- The Importance of PRIDE in Building an Inclusive Public Health Community

PrEP therapy has revolutionized HIV treatment by protecting patients who are high risk for acquiring the virus.

The Importance of Pre-Exposure Prophylaxis for HIV

Fosamprenavir calcium (Lexiva ) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Daily Medication Pearl: Fosamprenavir Calcium (Lexiva)

Pharmacies can help bring inequities plaguing health care systems to an end to ensure the COVID-19 pandemic does not follow trends of inequity experienced in the HIV pandemic.

Data Show Inequities From the HIV, COVID-19 Pandemics Remain Left to Be Addressed

Ritonavir (Norvir) is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection.

Daily Medication Pearl: Ritonavir (Norvir)

PQA is also committed to national goals related to HIV and reducing HIV ending the epidemic.

Health Care Professionals Should Walk Away with Practical Resources from New HIV Course

Symtuza, a 4-drug combination of darunavir (DRV), a HIV-1 protease inhibitor; cobicistat (COBI), a CYP3A inhibitor; and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 nucleoside analog reverse transcriptase inhibitors, is indicated as a complete regimen for the treatment of HIV-1 infection in patients who weigh at least 40 kg.

Daily Medication Pearl: Symtuza (Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide)

Prezista is an protease inhibitor indicated for the treatment of HIV-1 infection in patients aged 3 years and older.

Daily Medication Pearl: Prezista (Darunavir)

It's extremely important for pharmacists to be involved in helping care for people who have HIV.

HIV Course Focuses on Quality Measurement in the Pharmacy

Ibalizumab-uiyk (Trogarzo, Theratechnologies) is an injectable CD4-directed post-attachment HIV-1 inhibitor for the treatment of HIV type 1 infection in heavily treatment-experienced adults.

Pharmacist Medication Insights: Ibalizumab (Trogarzo) for HIV

® HIV Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of HIV, a virus that attacks the body's immune system and, if left untreated, can lead to AIDS.